Aarvik Therapeutics

Fremont, United States

Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.

$2.0M raised

Sep 2025

Seed

Biotechnology Life Science Oncology

Top Investors

Laurus Labs

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aarvik Therapeutics

How much funding has Aarvik Therapeutics raised?

Aarvik Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in September 2025.

Who are Aarvik Therapeutics's investors?

Aarvik Therapeutics's investors include Laurus Labs.

Where is Aarvik Therapeutics headquartered?

Aarvik Therapeutics is headquartered in Fremont, United States.

What does Aarvik Therapeutics do?

Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.

What stage is Aarvik Therapeutics at?

Aarvik Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 29, 2025.

MLA

"Aarvik Therapeutics — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/aarvik-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2025). Aarvik Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/aarvik-therapeutics

Wikipedia (cite web)

{{cite web |title=Aarvik Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aarvik-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 29, 2025.